U.S. Venture Partners
Minneapolis
Also known as U.S. Bancorp Asset Management, Inc.
What they invest in
from 8 of 8 portfolio companiesEnterprise Software Γ3Healthtech Γ3Medical Devices Γ3AI & Machine Learning Γ2Developer Tools Γ2Hardware Γ2SaaS Γ2Biotech Γ1
HQs:United StatesΓ5
Investments Β· 8 tracked
founders shown can be your intro pathBy year:2026 Β· 22025 Β· 12024 Β· 22023 Β· 16 dated
Adaptive provides a cloud cost optimization platform that detects, remediates, and prevents "shadow waste" and inefficiencies across multi-cloud, Kubernetes, AI platforms, data cloud, and code.
AI & Machine LearningCloud ComputingDeveloper Tools
Aviv Revach(Founder)Eyal Brosh(Founder)
Co-investorsForgePoint CapitalLaunchpad CapitalNew Era Capital PartnersUS Venture PartnersNew Era CapitalPitango+1 more
Cagent Vascular develops endovascular medical devices, including the Serranator PTA Serration Balloon Catheter, for the treatment of vascular disease.
HardwareHealthtechMedical DevicesWayne, US
Brian Walsh(Chairman & CEO)inPeter Johansson(Chief Quality & Compliance Officer, VP Engineering)inPaul Wilson(Chief Commercial Officer)inMatt Condron(SVP of Operations)inCorey Latanision(SVP of Marketing & International Sales)inPeter Schneider(Chief Medical Advisor, Co-Founder)
Co-investorsUS Venture PartnersAstoria Health Investors
Imperva provides cybersecurity solutions to protect customers from cyberattacks across applications, data, and identities during digital transformation.
CybersecurityEnterprise SoftwareSan Mateo, US
Shlomo Kramer(Co-Founder, President & CEO (early years))Amichai Shulman(Co-Founder & CTO)Mickey Boodaei(Co-Founder)Pam Murphy(CEO)Chris Hylen(President & CEO)Charles Goodman(Interim CEO)
Co-investorsAccelAspect VenturesCore Ventures GroupDigi VenturesForgePoint CapitalSAV (Scale Asia Ventures)+6 more
NuXcel is a global medical device accelerator that founds and incubates bioelectronics and neuromodulation startups addressing large unmet clinical needs, using a lean innovation model.
Deep TechHealthtechMedical Devices
Co-investorsTreo Ventures, LlcAmzak HealthAPERTURE Venture PartnersNorwest Venture PartnersOSF Ventures
ShiraTronics is a medical device company developing an implantable device to treat chronic migraine disease.
BiotechHardwareHealthtechMedical DevicesBrooklyn Park, US
Robert Binney(Executive Officer, Director)
BoardJoyce Erony(Director)inZack Scott(Director)Brad Vale(Director)inCasey Tansey(Director)Mudit Jain(Executive Officer, Director)
Co-investorsAmzak HealthAPERTURE Venture PartnersBreakout VenturesGlobal BioAccess FundNorwest Venture PartnersOSF Ventures+3 more
Simplee was a healthcare financial technology company that provided a patient financial engagement platform, helping hospitals and health systems offer transparent billing, estimates, and payment experiences.
Enterprise SoftwareFintechSaaSPalo Alto, US
Tomer Shoval(Co-Founder & CEO)Roberto Rabinovich(Co-Founder & COO)Tom Tsarfati(Co-Founder & CTO)Derick Sutton(Chief Financial Officer)John Dwight(Executive (role unconfirmed))Joel Haferbecker(Executive (role unconfirmed))
Co-investors83NorthGreylock Partners
Smartling provides enterprise-grade localization and translation software with APIs, SDKs, and CI/CD integrations for software development teams.
AI & Machine LearningDeveloper ToolsEnterprise SoftwareMarketing TechSaaS
Jack Welde(Founder)in
Co-investorsAccelerator VenturesBattery VenturesHarmony PartnersICONIQRidge VenturesTenaya Capital+4 more
ZERO is a decentralized, privacy-focused messaging and social platform, offering products including a messenger, social app, and digital identity (Zero ID) built on a crypto protocol with its own token.
ConsumerCrypto & Web3Social
Co-investorsRed Beard VenturesF2 Venture CapitalHighland EuropePICO Venture PartnersVenrock
Exits Β· 1
IPOs and acquisitions across the tracked portfolioSimpleeacq. by Flywire
Portfolio news
latest coverage across their companies
Cagent Vascular Β· intelligence360.news Β· Jun 3, 2026
Zero Β· finsmes.com Β· Mar 16, 2026
Adaptive6 Β· ucapital.com Β· Jan 29, 2026
NuXcel Β· finsmes.com Β· Nov 11, 2025
Fund performance Β· per public LP disclosures Β· 3
as of Sep 2025| Fund | Vintage | Committed | Net IRR | TVPI | DPI |
|---|---|---|---|---|---|
| U.S. Venture Partners VIII, L.P.LPs: Washington State Investment Board, Hawaii Employees' Retirement System, Rockefeller Foundation | 2001 | β | 3.5% | 1.30x | 1.30x |
| U.S. Venture Partners VII, L.P.LPs: Washington State Investment Board, Hawaii Employees' Retirement System, Rockefeller Foundation | 2000 | β | -2.5% | 0.70x | 0.70x |
| U.S. Venture Partners V, L.P.LPs: Washington State Investment Board | 1996 | β | 26.2% | 2.30x | 2.26x |
Source: public limited-partner disclosures (CalPERS, CalSTRS). Net IRR / TVPI / DPI as reported by the limited partner; a fund's early-year IRR is an interim estimate (J-curve).
Frequently asked questions
- Where is U.S. Venture Partners located?
- U.S. Venture Partners is headquartered in Minneapolis.
- Does U.S. Venture Partners lead rounds?
- U.S. Venture Partners has led 4 of the 13 rounds where its role is on record.
- Who does U.S. Venture Partners co-invest with?
- U.S. Venture Partners most often shares deals with 83North, Accel, Aspect Ventures, among 10 tracked co-investors.